Charles Schwab Investment Management Inc Silverback Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Silverback Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 345,295 shares of SBTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
345,295
Previous 329,550
4.78%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding SBTX
# of Institutions
117Shares Held
47.9MCall Options Held
442KPut Options Held
42K-
Deerfield Management Company, L.P. (Series C) New York, NY11.1MShares$00.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA9.24MShares$00.0% of portfolio
-
Sr One Capital Management, LP4.01MShares$00.0% of portfolio
-
Franklin Resources Inc San Mateo, CA2.95MShares$00.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.89MShares$00.0% of portfolio
About Silverback Therapeutics, Inc.
- Ticker SBTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,473,800
- Description
- Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...